Viracta Therapeutics, Inc.

Historical 13F Holders

Symbol
VIRX
CUSIP
867328700
All holders as of
Q4 2020
Type
Equity
Class
COM PAR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2020 Q4 5 1.40 M $2.56 M
2020 Q3 6 1.44 M $1.65 M
2020 Q2 48 37.8 M $9.95 M
2020 Q1 55 67.5 M $28.0 M
2019 Q4 51 58.7 M $19.8 M
2019 Q3 55 59.1 M $42.5 M
2019 Q2 54 36.6 M $26.7 M
2019 Q1 51 30.1 M $36.6 M
2018 Q4 46 15.6 M $6.49 M
2018 Q3 57 16.5 M $33.0 M
2018 Q2 59 15.8 M $33.6 M
2018 Q1 58 18.0 M $48.8 M
2017 Q4 46 18.2 M $67.2 M
2017 Q3 41 13.1 M $25.4 M
2017 Q2 43 13.5 M $36.5 M
2017 Q1 47 11.9 M $48.8 M
2016 Q4 56 11.9 M $42.9 M
2016 Q3 49 6.65 M $29.1 M